Pharmaceutics · Short notes

Novel Drug Delivery Systems: Short Notes & Cheat Sheet

Drug Delivery Systems II and Pharmaceutical Technology II: modified release, matrix and reservoir systems, osmotic pumps, gastroretentive and colon-targeted systems, transdermal patches, liposomes and nanocarriers.

Short notes

Read these before you attempt the topic's MCQs.

Novel drug delivery systems

MatrixHPMC gel; Higuchi √t releaseOsmotic pumpLaser-drilled orifice; zero-orderGastroretentiveFloating, swelling, mucoadhesiveColon-targetedpH polymers, azo prodrugsTransdermalPotent, small, lipophilic drugsNanocarriersLiposomes, niosomes, EPR effectNDDS
Each system solves a different problem: how fast, where, or by which route the drug is released.

Modified release

  • Extended (sustained or prolonged) release spreads release over time; delayed release (enteric coating) holds the drug back until the intestine; targeted release aims at a site.
  • Controlled release ideally gives zero-order release, so plasma levels stay flat and doses are fewer.
  • Poor candidates: drugs with a very long half-life, a narrow absorption window, very large doses or a need for precise titration.
  • Modified-release tablets must not be crushed or chewed; dose dumping can cause toxicity.

How release is controlled

  • Matrix systems disperse the drug in a polymer such as HPMC that swells into a gel; release follows the Higuchi square-root-of-time model.
  • Reservoir systems surround a drug core with a rate-controlling membrane and give near zero-order release.
  • Osmotic pumps (OROS) have a semipermeable cellulose acetate coat with a laser-drilled orifice; release is zero-order and largely independent of pH and gut motility (nifedipine GITS).
  • Gastroretentive systems stay in the stomach by floating (bicarbonate gas, density below gastric fluid), swelling or mucoadhesion.
  • Colon targeting uses pH-dependent polymers (Eudragit S dissolves above pH 7) or prodrugs split by colonic bacteria (sulfasalazine's azo bond).

Transdermal patches

  • Patch types: reservoir with a rate-controlling membrane, matrix, and drug-in-adhesive.
  • A good transdermal drug is potent (low daily dose), small (molecular weight under about 500 Da) and moderately lipophilic.
  • Examples: glyceryl trinitrate, fentanyl, buprenorphine, nicotine, hyoscine (motion sickness), estradiol, clonidine and rivastigmine.

Targeted and nanocarrier systems

  • Liposomes are phospholipid bilayer vesicles. Liposomal amphotericin B is less nephrotoxic; PEGylated (stealth) liposomal doxorubicin circulates longer and spares the heart.
  • Niosomes use non-ionic surfactants instead of phospholipids; other carriers include polymeric nanoparticles, microspheres and dendrimers.
  • Passive targeting uses the leaky tumour vessels of the enhanced permeability and retention (EPR) effect; active targeting adds ligands or antibodies (antibody–drug conjugates).
  • Long-acting depot injections use biodegradable PLGA microspheres, for example leuprolide.

Cheat sheet

High-yield facts in one place. Cover the right-hand column and test yourself.

System → example

SystemExample
Osmotic pump (OROS)Nifedipine GITS, methylphenidate
Hydrophilic matrixHPMC extended-release tablets
Enteric coatingDelayed-release PPIs, aspirin EC
Colon targeting (prodrug)Sulfasalazine, olsalazine
TransdermalFentanyl, nicotine, hyoscine
LiposomeAmphotericin B, doxorubicin
PLGA depotLeuprolide microspheres

Release models

ModelEquation · applies to
Zero-orderQ = k₀t · osmotic pump, reservoir
First-orderln(remaining) falls linearly · conventional
HiguchiQ = k√t · matrix diffusion
Korsmeyer–PeppasMt/M∞ = ktⁿ · n shows the mechanism

Memory aids

Osmotic = Orderly zero
Osmotic pumps give zero-order release regardless of stomach pH or food.

Exam traps

  • Enteric coating is delayed release, not sustained release.
  • Matrix release follows the square root of time (Higuchi); reservoir and osmotic systems approach zero-order.
  • PEGylation lengthens circulation time by hiding liposomes from macrophages.
  • Never crush or split a modified-release tablet unless it is scored for that purpose.

Revised? Now test yourself.

Attempt the Novel Drug Delivery Systems MCQs while the notes are fresh. Anything you get wrong is saved to your incorrect list for the next revision round.

More Pharmaceutics notes